The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation

dc.contributor.authorSchneider, Taiane
dc.contributor.authorMartinez-Martinez, Arturo
dc.contributor.authorCubillos Rojas, Mónica
dc.contributor.authorBartrons Bach, Ramon
dc.contributor.authorVentura Pujol, Francesc
dc.contributor.authorRosa López, José Luis
dc.date.accessioned2018-11-09T13:28:13Z
dc.date.available2018-11-09T13:28:13Z
dc.date.issued2018-07-31
dc.date.updated2018-11-09T13:28:13Z
dc.description.abstractThe RAF/MEK/ERK cascade is a conserved intracellular signaling pathway that controls fundamental cellular processes including growth, proliferation, differentiation, survival and migration. Aberrant regulation of this signaling pathway has long been associated with human cancers. A major point of regulation of this pathway occurs at the level of the serine/threonine protein kinase C-RAF. Here, we show how the E3 ubiquitin ligase HERC1 regulates ERK signaling. HERC1 knockdown induced cellular proliferation, which is associated with an increase in ERK phosphorylation and in C-RAF protein levels. We demonstrate that overexpression of wild-type C-RAF is sufficient to increase ERK phosphorylation. Experiments with pharmacological inhibitors of RAF activity, or with interference RNA, show that the regulation of ERK phosphorylation by HERC1 is RAF-dependent. Immunoprecipitation, pull-down and confocal fluorescence microscopy experiments demonstrate an interaction between HERC1 and C-RAF proteins. Mechanistically, HERC1 controls C-RAF stability by regulating its polyubiquitylation in a lysine 48-linked chain. In vitro ubiquitylation assays indicate that C-RAF is a substrate of the E3 ubiquitin ligase HERC1. Altogether, we show how HERC1 can regulate cell proliferation through the activation of ERK signaling by a mechanism that affects C-RAF's stability.
dc.format.extent18 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec681514
dc.identifier.issn1949-2553
dc.identifier.pmid30140388
dc.identifier.urihttps://hdl.handle.net/2445/125949
dc.language.isoeng
dc.publisherImpact Journals
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.18632/oncotarget.25847
dc.relation.ispartofOncotarget, 2018, vol. 9, num. 59, p. 31531-31548
dc.relation.urihttps://doi.org/10.18632/oncotarget.25847
dc.rightscc-by (c) Schneider, Taiane et al., 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Ciències Fisiològiques)
dc.subject.classificationUbiqüitina
dc.subject.classificationProteïnes de membrana
dc.subject.classificationTransducció de senyal cel·lular
dc.subject.classificationRegulació cel·lular
dc.subject.otherUbiquitin
dc.subject.otherMembrane proteins
dc.subject.otherCellular signal transduction
dc.subject.otherCellular control mechanisms
dc.titleThe E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
681514.pdf
Mida:
6.3 MB
Format:
Adobe Portable Document Format